Solubility and dissolution enhancement strategies: current understanding and recent trends*
暂无分享,去创建一个
[1] Po-Chun Hsu,et al. A portable fiber-optic Raman analyzer for fast real-time screening and identifying cocrystal formation of drug-coformer via grinding process , 2013 .
[2] Peddy Vishweshwar,et al. Pharmaceutical co-crystals. , 2006, Journal of pharmaceutical sciences.
[3] G. Stephenson,et al. Physical stability of salts of weak bases in the solid-state. , 2011, Journal of pharmaceutical sciences.
[4] Kwok Chow,et al. Engineering of pharmaceutical materials: an industrial perspective. , 2008, Journal of pharmaceutical sciences.
[5] S. Onoue,et al. Physicochemical and pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability. , 2012, Drug metabolism and pharmacokinetics.
[6] S. Velaga,et al. Hansen solubility parameter as a tool to predict cocrystal formation. , 2011, International journal of pharmaceutics.
[7] P. Reusser. Oral valganciclovir: a new option for treatment of cytomegalovirus infection and disease in immunocompromised hosts , 2001, Expert opinion on investigational drugs.
[8] Carlos E Figueroa,et al. Spray granulation: importance of process parameters on in vitro and in vivo behavior of dried nanosuspensions. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[9] M. Meunier,et al. Nanonization of megestrol acetate by laser fragmentation in aqueous milieu. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[10] David R. Weyna,et al. Synthesis and Structural Characterization of Cocrystals and Pharmaceutical Cocrystals: Mechanochemistry vs Slow Evaporation from Solution , 2009 .
[11] C. C. Seaton,et al. Applying Hot-Stage Microscopy to Co-Crystal Screening: A Study of Nicotinamide with Seven Active Pharmaceutical Ingredients , 2008 .
[12] Aeri Park,et al. Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API , 2006, Pharmaceutical Research.
[13] Shobha N. Bhattachar,et al. Solubility: it's not just for physical chemists. , 2006, Drug discovery today.
[14] Tommy Liljefors,et al. Aqueous solubility study of salts of benzylamine derivatives and p-substituted benzoic acid derivatives using X-ray crystallographic analysis. , 2004, International journal of pharmaceutics.
[15] Xing Tang,et al. In vitro and in vivo evaluation of fenofibrate solid dispersion prepared by hot-melt extrusion , 2010, Drug development and industrial pharmacy.
[16] P. Chaudhari,et al. Solubility enhancement of hydrophobic drugs using synergistically interacting cyclodextrins and cosolvent , 2007 .
[17] Ravi M Shanker,et al. Aqueous solubility of crystalline and amorphous drugs: Challenges in measurement , 2011, Pharmaceutical development and technology.
[18] Atsuo Ohike,et al. Establishment of new preparation method for solid dispersion formulation of tacrolimus. , 2003, International journal of pharmaceutics.
[19] Yihui Deng,et al. Effect of particle size on solubility , dissolution rate , and oral bioavailability : evaluation using coenzyme Q 10 as naked nanocrystals , 2012 .
[20] H W Frijlink,et al. A novel bottom-up process to produce drug nanocrystals: controlled crystallization during freeze-drying. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[21] Manfred Kansy,et al. High throughput solubility measurement in drug discovery and development. , 2007, Advanced drug delivery reviews.
[22] K. Srinivasan,et al. Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[23] K. G. Desai,et al. Solubility studies on valdecoxib in the presence of carriers, cosolvents, and surfactants , 2004 .
[24] M. Brewster,et al. Solvent systems and their selection in pharmaceutics and biopharmaceutics , 2007 .
[25] S. Yalkowsky,et al. Solubility of nonelectrolytes in polar solvents III: Alkyl p-aminobenzoates in polar and mixed solvents. , 1975, Journal of pharmaceutical sciences.
[26] J. Swarbrick,et al. Encyclopedia of Pharmaceutical Technology , 2006 .
[27] Anant Paradkar,et al. Characterization of curcumin-PVP solid dispersion obtained by spray drying. , 2004, International journal of pharmaceutics.
[28] Amy D. Fung,et al. Water-soluble prodrugs of an Aurora kinase inhibitor. , 2009, Bioorganic & medicinal chemistry letters.
[29] E. Squillante,et al. Formulation development of Carbamazepine–Nicotinamide co-crystals complexed with γ-cyclodextrin using supercritical fluid process , 2011 .
[30] W. Hinrichs,et al. Bottom-Up Preparation Techniques for Nanocrystals of Lipophilic Drugs , 2010, Pharmaceutical Research.
[31] Kevin S. Eccles,et al. Characterisation, solubility and intrinsic dissolution behaviour of benzamide: dibenzyl sulfoxide cocrystal. , 2012, International journal of pharmaceutics.
[32] Hassan Almoazen,et al. Investigation of Solubility and Dissolution of a Free Base and Two Different Salt Forms as a Function of pH , 2005, Pharmaceutical Research.
[33] Hoo-Kyun Choi,et al. Improved absorption of meloxicam via salt formation with ethanolamines. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[34] P. Panchmatia,et al. The influence of salt formation on electrostatic and compression properties of flurbiprofen salts. , 2013, International journal of pharmaceutics.
[35] M. Du,et al. Norfloxacin salts with benzenedicarboxylic acids: charge-assisted hydrogen-bonding recognition and solubility regulation , 2013 .
[36] Filippos Kesisoglou,et al. Nanosizing--oral formulation development and biopharmaceutical evaluation. , 2007, Advanced drug delivery reviews.
[37] P. L. Gould,et al. Salt selection for basic drugs , 1986 .
[38] S. Yalkowsky,et al. Solubility Improvement of Drugs using N-Methyl Pyrrolidone , 2008, AAPS PharmSciTech.
[39] Hoo-Kyun Choi,et al. Enhancement of solubility and dissolution of coenzyme Q10 using solid dispersion formulation. , 2010, International journal of pharmaceutics.
[40] A. Shevchenko,et al. A new cocrystal and salts of itraconazole: comparison of solid-state properties, stability and dissolution behavior. , 2012, International journal of pharmaceutics.
[41] Ying Zheng,et al. Stability of nanosuspensions in drug delivery. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[42] N. Rodríguez-Hornedo,et al. Screening strategies based on solubility and solution composition generate pharmaceutically acceptable cocrystals of carbamazepine , 2008 .
[43] Alfred N. Martin. Physical Pharmacy: Physical Chemical Principles in the Pharmaceutical Sciences , 1969 .
[44] Eva Roblegg,et al. Nano-extrusion: a One-Step Process for Manufacturing of Solid Nanoparticle Formulations Directly from the Liquid Phase , 2013, AAPS PharmSciTech.
[45] Naír Rodríguez-Hornedo,et al. Solubility Advantage of Pharmaceutical Cocrystals , 2009 .
[46] C. Galli. Experimental determination of the diffusion boundary layer width of micron and submicron particles. , 2006, International journal of pharmaceutics.
[47] Marcel Jaspars,et al. Hydrocortisone Nanosuspensions for Ophthalmic Delivery : A Comparative Study between Microfluidic Nanoprecipitation and Wet Milling , 2013 .
[48] Richard J. Bastin,et al. Salt Selection and Optimisation Procedures for Pharmaceutical New Chemical Entities , 2000 .
[49] D. Good,et al. Cocrystal Eutectic Constants and Prediction of Solubility Behavior , 2010 .
[50] P Augustijns,et al. Characterization of physico-chemical properties and pharmaceutical performance of sucrose co-freeze-dried solid nanoparticulate powders of the anti-HIV agent loviride prepared by media milling. , 2007, International journal of pharmaceutics.
[51] L. S. Taylor,et al. Stability and solubility enhancement of ellagic acid in cellulose ester solid dispersions. , 2013, Carbohydrate polymers.
[52] Thomas Rades,et al. Emerging trends in the stabilization of amorphous drugs. , 2013, International journal of pharmaceutics.
[53] K. Matsuzaki,et al. Solubility enhancement of hydrophobic compounds by cosolvents: role of solute hydrophobicity on the solubilization effect. , 2010, International journal of pharmaceutics.
[54] E. Bosch,et al. Solubility-pH profiles of some acidic, basic and amphoteric drugs. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[55] J. F. Liebman,et al. ESTIMATING ENTROPIES AND ENTHALPIES OF FUSION OF ORGANIC COMPOUNDS , 1991 .
[56] Patrick Sandra,et al. The utility of sulfonate salts in drug development. , 2010, Journal of pharmaceutical sciences.
[57] Jeanette T. Dunlap,et al. Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids. , 2004, Journal of the American Chemical Society.
[58] K. Shing,et al. Supercritical fluid-micronized ipratropium bromide for pulmonary drug delivery , 2008 .
[59] Dave A. Miller,et al. KinetiSol: A new processing paradigm for amorphous solid dispersion systems , 2012 .
[60] J. Crison,et al. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.
[61] Naír Rodríguez-Hornedo,et al. Understanding and Predicting the Effect of Cocrystal Components and pH on Cocrystal Solubility , 2009 .
[62] D. Hofmann,et al. Lattice energy calculation – A quick tool for screening of cocrystals and estimation of relative solubility. Case of flavonoids , 2013 .
[63] Yihui Deng,et al. Effect of particle size on solubility, dissolution rate, and oral bioavailability: evaluation using coenzyme Q10 as naked nanocrystals , 2012, International journal of nanomedicine.
[64] Hirofumi Takeuchi,et al. Particle design of poorly water-soluble drug substances using supercritical fluid technologies. , 2008, Advanced drug delivery reviews.
[65] R. Davey,et al. Making Co-crystals-The utility of ternary phase diagrams , 2007 .
[66] Y. Pore,et al. Improvement in physicochemical properties of ezetimibe using a crystal engineering technique , 2012 .
[67] K. Mahesh,et al. A comparative study of top-down and bottom-up approaches for the preparation of nanosuspensions of glipizide , 2014 .
[68] R. Liu. Water-Insoluble Drug Formulation, Second Edition , 2008 .
[69] Y. Zu,et al. Preparation and characterization of vitexin powder micronized by a supercritical antisolvent (SAS) process , 2012 .
[70] C. Mueller. Prodrug Approaches for Enhancing the Bioavailability of Drugs with Low Solubility. , 2010 .
[71] R. Liu. Water-insoluble drug formulation , 2000 .
[72] D. Law,et al. Ritonavir-PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluations. , 2004, Journal of pharmaceutical sciences.
[73] V. Ranade,et al. Biotechnology: Pharmaceutical Aspects , 2010 .
[74] T. Tay,et al. Counter-intuitive enhancement in the dissolution of indomethacin with the incorporation of cohesive poorly water-soluble inorganic salt additives. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[75] A. Bansal,et al. Effect of counterions on the properties of amorphous atorvastatin salts. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[76] James E. Kipp,et al. Solubilizing Systems for Parenteral Formulation Development—Small Molecules , 2007 .
[77] Beatrice Perissutti,et al. Enhanced Oral Bioavailability of Vinpocetine Through Mechanochemical Salt Formation: Physico-Chemical Characterization and In Vivo Studies , 2011, Pharmaceutical Research.
[78] Henrique A. Matos,et al. Screening for pharmaceutical cocrystals using the supercritical fluid enhanced atomization process , 2010 .
[79] A. Aggarwal,et al. Physicochemical characterization and dissolution study of solid dispersions of diacerein with polyethylene glycol 6000 , 2011, Drug development and industrial pharmacy.
[80] Naír Rodríguez-Hornedo,et al. Dependence of cocrystal formation and thermodynamic stability on moisture sorption by amorphous polymer , 2011 .
[81] Ram B. Gupta,et al. Formation of itraconazole/L-malic acid cocrystals by gas antisolvent cocrystallization , 2013 .
[82] M. S. Ku,et al. A biopharmaceutical classification-based Right-First-Time formulation approach to reduce human pharmacokinetic variability and project cycle time from First-In-Human to clinical Proof-Of-Concept , 2012, Pharmaceutical development and technology.
[83] Z T Chowhan,et al. pH-solubility profiles or organic carboxylic acids and their salts. , 1978, Journal of pharmaceutical sciences.
[84] Hywel D Williams,et al. Strategies to Address Low Drug Solubility in Discovery and Development , 2013, Pharmacological Reviews.
[85] C. Clark,et al. Effect of Cosolvents on Toxaphene Aqueous Solubility , 2006 .
[86] Alfonso R. Gennaro,et al. Remington:the science and practice of pharmacy , 1995 .
[87] Geert Verreck,et al. Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast- and slow-dissolving polymers. , 2004, Journal of pharmaceutical sciences.
[88] C. Müller,et al. Prodrug Approaches for Enhancing the Bioavailability of Drugs with Low Solubility , 2009, Chemistry & biodiversity.
[89] Patrick Augustijns,et al. Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? , 2009, Journal of pharmaceutical sciences.
[90] Koichi Wada,et al. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. , 2011, International journal of pharmaceutics.
[91] Longqin Hu. Prodrugs: effective solutions for solubility, permeability and targeting challenges. , 2004, IDrugs : the investigational drugs journal.
[92] Rainer H Müller,et al. Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[93] R. Holm,et al. Aqueous solubility: simple predictive methods (in silico, in vitro and bio-relevant approaches). , 2013, International journal of pharmaceutics.
[94] S. Yalkowsky,et al. Solubility and partitioning I: Solubility of nonelectrolytes in water. , 1980, Journal of pharmaceutical sciences.
[95] Jun-Shik Choi,et al. Enhanced bioavailability of piroxicam via salt formation with ethanolamines. , 2005, International journal of pharmaceutics.
[96] Lynne S. Taylor,et al. Understanding the Behavior of Amorphous Pharmaceutical Systems during Dissolution , 2010, Pharmaceutical Research.
[97] Michael Lee Branham,et al. Preparation and solid-state characterization of ball milled saquinavir mesylate for solubility enhancement. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[98] George Zografi,et al. Assessing the performance of amorphous solid dispersions. , 2012, Journal of pharmaceutical sciences.
[99] N. Rodríguez-Hornedo,et al. Cocrystals and Salts of Gabapentin: pH Dependent Cocrystal Stability and Solubility , 2009 .
[100] S. Onoue,et al. Improved dissolution and pharmacokinetic behavior of cyclosporine A using high-energy amorphous solid dispersion approach. , 2010, International journal of pharmaceutics.
[101] Raviraj M. Kulkarni,et al. Nanosuspensions: a promising drug delivery strategy , 2004, The Journal of pharmacy and pharmacology.
[102] R. Bogner,et al. Application of mesoporous silicon dioxide and silicate in oral amorphous drug delivery systems. , 2012, Journal of pharmaceutical sciences.
[103] Abu T M Serajuddin,et al. Effect of chloride ion on dissolution of different salt forms of haloperidol, a model basic drug. , 2005, Journal of pharmaceutical sciences.
[104] I. Kellaway,et al. Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles. , 2006, International journal of pharmaceutics.
[105] K. Amighi,et al. Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[106] T. Kojima,et al. Characterization and evaluation of miconazole salts and cocrystals for improved physicochemical properties. , 2011, International journal of pharmaceutics.
[107] W. Acree,et al. Solubility of Pioglitazone Hydrochloride in Aqueous Solutions of Ethanol, Propylene Glycol, and N-Methyl-2-Pyrrolidone at 298.2°K , 2009, AAPS PharmSciTech.
[108] B. Perissutti,et al. Drug salt formation via mechanochemistry: the case study of vincamine. , 2013, Molecular pharmaceutics.
[109] Lynne S Taylor,et al. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[110] James W McGinity,et al. Fusion processing of itraconazole solid dispersions by kinetisol dispersing: a comparative study to hot melt extrusion. , 2010, Journal of pharmaceutical sciences.
[111] Shobha Bhattachar,et al. The road map to oral bioavailability: an industrial perspective , 2006, Expert opinion on drug metabolism & toxicology.
[112] Elies Molins,et al. Effect of the Counterion on the Solubility of Isostructural Pharmaceutical Lamotrigine Salts , 2009 .
[113] Abu T M Serajuddin,et al. Salt formation to improve drug solubility. , 2007, Advanced drug delivery reviews.
[114] Yoshiki Hayashi,et al. Dissolution Improvement and the Mechanism of the Improvement from Cocrystallization of Poorly Water-soluble Compounds , 2008, Pharmaceutical Research.
[115] A. Klamt,et al. Rational coformer or solvent selection for pharmaceutical cocrystallization or desolvation. , 2012, Journal of pharmaceutical sciences.
[116] Dongmei Cun,et al. Effect of Crystal Size on the In Vitro Dissolution and Oral Absorption of Nitrendipine in Rats , 2010, Pharmaceutical Research.
[117] Shigeo Kojima,et al. Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions. , 2004, Journal of pharmaceutical sciences.
[118] Gert Fricker,et al. The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility , 2012, International journal of nanomedicine.
[119] Gareth R. Williams,et al. Polymer-based nanoparticulate solid dispersions prepared by a modified electrospraying process , 2011 .
[120] Lokesh Kumar,et al. Preparation and characterization of salt forms of enalapril. , 2008, Pharmaceutical development and technology.
[121] A. Healy,et al. Preparation and characterisation of novel chlorothiazide potassium solid-state salt forms: Intermolecular self assembly suprastructures. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[122] J. Breitkreutz,et al. Improved group contribution parameter set for the application of solubility parameters to melt extrusion. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[123] Gautam R. Desiraju,et al. Supramolecular Synthons in Crystal Engineering—A New Organic Synthesis , 1995 .
[124] P. Gao,et al. Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. , 2003, Journal of pharmaceutical sciences.
[125] E. Ferreira,et al. Synthesis and in vitro evaluation of potential antichagasic hydroxymethylnitrofurazone (NFOH-121): a new nitrofurazone prodrug. , 2003, Bioorganic & medicinal chemistry.
[126] Abolghasem Jouyban,et al. Review of the cosolvency models for predicting solubility of drugs in water-cosolvent mixtures. , 2008, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[127] J. Schellens,et al. Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[128] T. Rades,et al. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[129] Jan P Möschwitzer,et al. Drug nanocrystals in the commercial pharmaceutical development process. , 2013, International journal of pharmaceutics.
[130] Jianjun Zhang,et al. Coformer selection based on degradation pathway of drugs: a case study of adefovir dipivoxil-saccharin and adefovir dipivoxil-nicotinamide cocrystals. , 2012, International journal of pharmaceutics.
[131] P Timmins,et al. Impact of the counterion on the solubility and physicochemical properties of salts of carboxylic acid drugs , 2012, Drug development and industrial pharmacy.
[132] James Mack,et al. Mechanochemistry: opportunities for new and cleaner synthesis. , 2012, Chemical Society reviews.
[133] Emmanuel Scheubel,et al. Miniaturized screening of polymers for amorphous drug stabilization (SPADS): rapid assessment of solid dispersion systems. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[134] Neera Singh,et al. Sorption of metolachlor and atrazine in fly ash amended soils: Comparison of optimized isotherm models , 2012, Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes.
[135] Jonathan Brown,et al. Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches. , 2009, International journal of pharmaceutics.
[136] I. Ghosh,et al. Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: effect of Vitamin E TPGS and nanocrystal particle size on oral absorption. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[137] Vinod P. Shah,et al. Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions , 2002, Pharmaceutical Research.
[138] S. Yalkowsky,et al. Solubilization of poorly soluble compounds using 2-pyrrolidone. , 2007, International journal of pharmaceutics.
[139] Rainer H Müller,et al. Nanocrystals: comparison of the size reduction effectiveness of a novel combinative method with conventional top-down approaches. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.